Novo Nordisk A S reported net income of $48.55B for the quarter ended Dec 2019. This income statement covers 20 quarters of results from Dec 2010 through Dec 2019, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2010 | Mar2012 | Jun2012 | Sep2012 | Dec2012 | Mar2013 | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Dec2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 4.80B | |||||||||||||||||||
| Revenue & cost | ||||||||||||||||||||
| Revenue | 3.13B | 3.36B | 3.34B | 3.64B | 3.54B | 3.75B | 3.64B | 3.95B | 3.73B | 3.98B | 3.96B | 88.81B | 3.81B | 4.00B | 3.99B | 107.93B | 4.02B | 4.17B | ||
| Gross Profit | 2.53B | 2.77B | 2.75B | 3.09B | 2.90B | 3.12B | 3.02B | 3.33B | 3.10B | 3.30B | 3.35B | 3.47B | 3.22B | 3.43B | 3.42B | 3.39B | 3.55B | 101.93B | ||
| Operating items | ||||||||||||||||||||
| Research & DevelopmentR&D | 0.44B | 0.44B | 0.44B | 0.56B | 0.47B | 0.48B | 0.50B | 0.65B | 0.58B | 0.57B | 0.65B | 0.65B | 0.49B | 0.45B | 0.49B | 0.49B | 0.51B | 14.22B | ||
| Restructuring CostsRestructuring | 0.14B | 0.13B | 0.13B | 0.17B | 0.14B | 0.14B | 0.14B | 0.20B | 0.15B | 0.15B | 0.15B | 0.18B | 0.13B | 0.13B | 0.14B | 0.13B | 0.13B | 4.01B | ||
| Other Operating ExpensesOther Opex | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.04B | 0.04B | 0.03B | 0.03B | 0.42B | 0.05B | 0.03B | 1.11B | 0.04B | 0.02B | 0.60B | |
| Operating ExpensesOpex | 0.58B | 0.58B | 0.57B | 0.73B | 0.61B | 0.62B | 0.64B | 0.84B | 0.73B | 0.71B | 0.81B | 0.83B | 0.62B | 0.58B | 0.63B | 0.62B | 0.64B | 18.23B | ||
| Operating IncomeOp. Inc | 1.13B | 1.32B | 1.32B | 1.32B | 1.34B | 1.50B | 1.42B | 1.34B | 1.47B | 1.61B | 1.52B | 1.54B | 2.09B | 1.84B | 1.78B | 1.63B | 1.82B | 1.90B | 83.71B | |
| EBIT | 1.13B | 1.32B | 1.32B | 1.32B | 1.34B | 1.50B | 1.42B | 1.34B | 1.47B | 1.61B | 1.52B | 1.54B | 2.09B | 1.84B | 1.78B | 1.63B | 1.82B | 1.90B | 83.71B | |
| Non-operating items | ||||||||||||||||||||
| Non Operating Interest Expenses | 0.07B | 0.15B | 0.07B | 0.02B | 0.02B | 0.05B | 0.02B | 0.03B | 0.06B | 0.03B | 0.08B | -0.06B | 0.25B | 0.25B | 0.28B | 0.06B | 4.00B | |||
| Interest & Investment IncomeInt & Inv Inc | 0.01B | 0.03B | -0.01B | 0.00B | 0.06B | 0.07B | 0.07B | 0.11B | 0.11B | 0.07B | 0.06B | -0.21B | 0.04B | -0.03B | 0.00B | 0.00B | 0.00B | 0.01B | 0.07B | |
| Non Operating IncomeNon Op. Inc. | 0.37B | 0.01B | ||||||||||||||||||
| Net income details | ||||||||||||||||||||
| EBT | 1.07B | 1.20B | 1.24B | 1.29B | 1.38B | 1.52B | 1.47B | 1.42B | 0.34B | 0.37B | 0.35B | 0.30B | 1.89B | 1.56B | 1.51B | 1.63B | 1.76B | 1.91B | 48.55B | |
| Tax ProvisionsTaxes | 1.52B | 1.65B | 1.50B | 7.62B | 0.39B | 0.33B | 0.26B | 0.37B | 0.40B | |||||||||||
| Profit After TaxPAT | 0.82B | 0.92B | 0.95B | 1.00B | 1.06B | 1.18B | 1.14B | 1.10B | 1.19B | 1.29B | 1.15B | 1.09B | 1.49B | 1.23B | 1.25B | 1.21B | 1.40B | 1.51B | 48.55B | |
| Equity Income | 38.00B | 5.81B | 5.31B | 6.18B | 7.18B | 5.79B | 6.20B | 7.08B | 7.87B | 6.20B | 6.72B | 6.42B | 6.58B | 4.62B | 5.87B | 6.47B | 6.88B | 5.70B | 6.36B | |
| Income from Non-Controlling InterestsInc. Minority | -0.09B | -0.23B | ||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | 1.07B | 1.20B | 1.24B | 1.29B | 1.38B | 1.52B | 1.47B | 1.42B | -1.19B | -1.29B | -1.15B | -7.31B | 1.49B | 1.23B | 1.25B | 1.63B | 1.40B | 1.51B | 48.55B | |
| Consolidated Net IncomeConsol Net Inc. | 1.07B | 1.20B | 1.24B | 1.29B | 1.38B | 1.52B | 1.47B | 1.42B | -1.19B | -1.29B | -1.15B | -7.31B | 1.49B | 1.23B | 1.25B | 1.63B | 1.40B | 1.51B | 48.55B | |
| Income towards Parent CompanyParent Net Inc | 1.07B | 1.20B | 1.24B | 1.29B | 1.38B | 1.52B | 1.47B | 1.42B | -1.19B | -1.29B | -1.15B | -7.31B | 1.49B | 1.23B | 1.25B | 1.63B | 1.40B | 1.51B | 48.55B | |
| Net Income towards Common StockholdersNet Income | 1.07B | 1.20B | 1.24B | 1.29B | 1.38B | 1.52B | 1.47B | 1.42B | -1.19B | -1.29B | -1.15B | -7.31B | 1.49B | 1.23B | 1.25B | 1.63B | 1.40B | 1.51B | 48.55B | |
| Additional items | ||||||||||||||||||||
| EPS (Basic) | 10.22 | |||||||||||||||||||
| EPS (Diluted) | 10.21 | |||||||||||||||||||
| Shares Outstanding | 4.75B | |||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 4.76B | |||||||||||||||||||
| EBITDA | 1.13B | 1.32B | 1.32B | 1.32B | 1.34B | 1.50B | 1.42B | 1.34B | 1.47B | 1.61B | 1.52B | 1.54B | 2.09B | 1.84B | 1.78B | 1.63B | 1.82B | 1.90B | 83.71B | |
| Interest ExpensesInt Expense | 0.07B | 0.15B | 0.07B | 0.02B | 0.02B | 0.05B | 0.02B | 0.03B | 0.06B | 0.03B | 0.08B | -0.06B | 0.25B | 0.25B | 0.28B | 0.06B | 4.00B | |||
| Tax Rate | 449.56 | 451.37 | 431.32 | 0.00B | 20.89 | 20.94 | 17.23 | 20.91 | 20.89 |